Skip to main content
ILSUNG IS CO., LTD. logo

ILSUNG IS CO., LTD. — Investor Relations & Filings

Ticker · 003120 ISIN · KR7003120003 KO Manufacturing
Filings indexed 212 across all filing types
Latest filing 2025-04-28 Board/Management Inform…
Country KR South Korea
Listing KO 003120

About ILSUNG IS CO., LTD.

https://www.ilsung.com/

ILSUNG IS CO., LTD. is a pharmaceutical company specializing in the development and manufacturing of therapeutic products. The company's core portfolio is focused on antibiotics, cardiovascular agents, anesthetics, and contrast media. It is actively expanding its research and development into new therapeutic areas, including treatments for gastrointestinal (GI), central nervous system (CNS), and other cardiovascular (CV) conditions.

Recent filings

Filing Released Lang Actions
대표이사(대표집행임원)변경(안내공시)
Board/Management Information Classification · 100% confidence The document is an official announcement regarding the appointment of new CEOs (representative directors) for the company Il-Sung I.S. It details the names of the individuals, the reasons for the change, the effective date, and their professional backgrounds. This falls directly under the category of board and management changes.
2025-04-28 Korean
[기재정정]사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a 'Correction Report' (정정신고) for an 'Annual Report' (사업보고서) filed by Ilsung Pharmaceuticals (일성신약). It explicitly states it is a correction to the previously submitted Annual Report (2024.12) to include missing information regarding treasury stock holdings. Since this is a formal amendment to the comprehensive annual financial report, it is classified as a 10-K (Annual Report). FY 2024
2025-04-14 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과). It details the approval of financial statements, dividend resolutions, and the election of board members and auditors. This falls under the category of Declaration of Voting Results & Voting Rights Announcements, as it provides the official outcome of shareholder votes.
2025-03-21 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment or dismissal of an outside director (사외이사). This type of corporate governance disclosure specifically relates to changes in the board of directors, which falls under the 'Board/Management Information' category.
2025-03-21 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal announcement titled '감사보고서 제출' (Submission of Audit Report) by Ilseong IS. It provides a summary table of financial data (assets, liabilities, revenue, net income) and confirms the audit opinion ('적정' - Unqualified) for the fiscal year ending 2024-12-31. While it contains financial data, it is a regulatory filing announcing the submission of the audit report to the exchange, rather than the full annual report or a standalone audit report document itself. Therefore, it fits the definition of a Regulatory Filing (RNS) or a report publication announcement, but given the specific nature of the audit submission notice in the Korean market, RNS is the most appropriate classification. FY 2024
2025-03-13 Korean
[첨부추가]사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) for the 65th fiscal period (2024-01-01 to 2024-12-31). It contains comprehensive financial statements, management discussion and analysis, governance information, and audit details, which are the standard components of an annual report in the South Korean regulatory framework (equivalent to a 10-K). FY 2024
2025-03-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.